compound E drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| compound E | targets | γ-secretase | — | 3 |
| organoids | interacts_with | compound E | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors. (2021)
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. (2018)
- Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells. (2016)
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. (2016)
- Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. (2016)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| compound e | drug | 5 | 9 |
| comp-e | drug | — | — |
| γ2 | drug | — | — |
| γ-secretase inhibitor compound e | drug | — | — |